|
KMID : 1123920160300050338
|
|
Korean Journal of Oriental Physiology and Pathology
2016 Volume.30 No. 5 p.338 ~ p.346
|
|
|
Gallic Acid Inhibits STAT3 Phosphorylation and Alleviates DDS-induced Colitis via Regulating Cytokine Production
|
|
Jeong Ji-Hyun
Kim Eun-Yeong
Choi Hee-Jung
Chung Tae-Wook
Kim Keuk-Jun
Kim So-Yeon
Ha Ki-Tae
|
|
|
Abstract
|
|
|
|
Signal transducer and activator of transcription 3 (STAT3) is associated with various human diseases, such as cancer, auto-immune disease, and intestinal inflammation. The limited and inadequate effect of standard approaches for treating inflammatory bowel disease (IBD) has prompted to develop alternative anti-colitis agents through inhibition of STAT3. Here, we show that gallic acid (GA), a 3,4,5-trihydroxybenzoic acid, markedly reduced phosphorylation of STAT3. Among the derivatives of benzoic acids, GA showed significant inhibition on STAT3 phosphorylation. In addition, GA ameliorated the dextran sodium sulfate (DSS)-induced acute colitis as determined by the measurement of symptomatic and histological indices. The suppression of DSS-induced acute colitis by GA treatment may be related to the regulation of cytokines and growth factors. Furthermore, GA inhibited phosphorylation of STAT3 in the colon tissue of DSS-treated mice. These findings may be useful in comprehending the molecular action of GA on STAT3 phosphorylation and provide novel insights into the potential application of GA in the treatment of STAT3-related inflammatory disease, such as IBD.
|
|
|
KEYWORD
|
|
|
STAT3, Gallic acid, Inflammatory bowel disease, Dextran sodium sulfate
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
|
|